![Infinity Pharmaceuticals, Inc. Logo](/news-release/logo/216379/0/216379.jpg?lastModified=12%2F09%2F2016%2022%3A45%3A34&size=2)
Infinity Initiates Randomized Phase 2 Trial of IPI-504, a Novel Hsp90 Inhibitor, in Non-Small Cell Lung Cancer
May 19, 2011 08:02 ET
|
Infinity Pharmaceuticals, Inc.
CAMBRIDGE, Mass., May 19, 2011 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI) today announced the initiation of a Phase 2 clinical trial of retaspimycin hydrochloride (HCl), also...
![Infinity Pharmaceuticals, Inc. Logo](/news-release/logo/216379/0/216379.jpg?lastModified=12%2F09%2F2016%2022%3A45%3A34&size=2)
Infinity Announces Clinical Data to be Presented at ASCO
May 19, 2011 07:58 ET
|
Infinity Pharmaceuticals, Inc.
CAMBRIDGE, Mass., May 19, 2011 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI) today announced that clinical data for IPI-926, its novel Smoothened antagonist, and retaspimycin...
![Infinity Pharmaceuticals, Inc. Logo](/news-release/logo/216379/0/216379.jpg?lastModified=12%2F09%2F2016%2022%3A45%3A34&size=2)
Infinity Reports First Quarter 2011 Financial Results
May 10, 2011 16:00 ET
|
Infinity Pharmaceuticals, Inc.
— Reaffirms 2011 Financial Guidance and Provides Additional Details —
— Anticipates Completion of Patient Enrollment in Phase 2 Trial of IPI-926 in Pancreatic Cancer...
![Infinity Pharmaceuticals, Inc. Logo](/news-release/logo/216379/0/216379.jpg?lastModified=12%2F09%2F2016%2022%3A45%3A34&size=2)
Infinity Announces the Date of Its First Quarter 2011 Financial Results Conference Call and Webcast
May 03, 2011 08:00 ET
|
Infinity Pharmaceuticals, Inc.
CAMBRIDGE, Mass., May 3, 2011 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI) will host a conference call on Tuesday, May 10, 2011 at 4:30 p.m. ET. During the call, management will...
![Infinity Pharmaceuticals, Inc. Logo](/news-release/logo/216379/0/216379.jpg?lastModified=12%2F09%2F2016%2022%3A45%3A34&size=2)
Infinity Announces Appointment of Joshua Hamermesh as Vice President, Business and Corporate Development
April 11, 2011 08:00 ET
|
Infinity Pharmaceuticals, Inc.
CAMBRIDGE, Mass., April 11, 2011 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI) today announced the appointment of Joshua D. Hamermesh as vice president, business and corporate...
![Infinity Pharmaceuticals, Inc. Logo](/news-release/logo/216379/0/216379.jpg?lastModified=12%2F09%2F2016%2022%3A45%3A34&size=2)
Infinity Pharmaceuticals to Present at BioCentury Future Leaders Conference
April 07, 2011 08:00 ET
|
Infinity Pharmaceuticals, Inc.
CAMBRIDGE, Mass., April 7, 2011 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI) will be presenting at BioCentury's 18th Annual Future Leaders in the Biotech Industry Conference on...
![Infinity Pharmaceuticals, Inc. Logo](/news-release/logo/216379/0/216379.jpg?lastModified=12%2F09%2F2016%2022%3A45%3A34&size=2)
Infinity Reports New Preclinical Data for IPI-926 at AACR Supporting Development in Chondrosarcoma
April 03, 2011 13:36 ET
|
Infinity Pharmaceuticals, Inc.
CAMBRIDGE, Mass., April 3, 2011 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI) today announced encouraging results for its novel Smoothened antagonist, IPI-926, in a preclinical...
![Infinity Pharmaceuticals, Inc. Logo](/news-release/logo/216379/0/216379.jpg?lastModified=12%2F09%2F2016%2022%3A45%3A34&size=2)
Infinity to Present New Preclinical Data on IPI-926, a Novel Smoothened Antagonist Targeting the Hedgehog Pathway, at Upcoming AACR Meeting
March 23, 2011 08:01 ET
|
Infinity Pharmaceuticals, Inc.
CAMBRIDGE, Mass., March 23, 2011 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI) today announced that the company will present new preclinical data supporting ongoing development of...
![Infinity Pharmaceuticals, Inc. Logo](/news-release/logo/216379/0/216379.jpg?lastModified=12%2F09%2F2016%2022%3A45%3A34&size=2)
Infinity Provides Company Update and Reports Fourth Quarter and Full-Year 2010 Financial Results
March 15, 2011 16:00 ET
|
Infinity Pharmaceuticals, Inc.
IPI-926 Advancing in Two Phase 2 Trials, Underscoring Pipeline Momentum
Cash Runway Into 2014 Enables Advancement of Product Candidates to
Key Inflection Points
Company Changes Accounting...
![Infinity Pharmaceuticals, Inc. Logo](/news-release/logo/216379/0/216379.jpg?lastModified=12%2F09%2F2016%2022%3A45%3A34&size=2)
Infinity Announces the Date of Its Fourth Quarter 2010 Financial Results Conference Call and Webcast
March 08, 2011 08:30 ET
|
Infinity Pharmaceuticals, Inc.
CAMBRIDGE, Mass., March 8, 2011 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI) will host a conference call on Tuesday, March 15, 2011 at 4:30 p.m. ET. During the call, management...